Development of a Virosomal RSV Vaccine Containing 3d-Phad® Adjuvant: Formulation, Composition, and Long-Term Stability

Pharmaceutical Research - United States
doi 10.1007/s11095-018-2453-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long-Term Efficacy of Oil-Adjuvant Influenza Vaccine in an Industrial Population

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
1967English

New Insights for Development of a Safe and Protective RSV Vaccine

Human Vaccines
2010English

Structural Characterization of a Protein Adsorbed on Aluminum Hydroxide Adjuvant in Vaccine Formulation

npj Vaccines
Infectious DiseasesImmunologyPharmacology
2019English

Giving RSV Vaccine Intranasally.

BMJ
1979English

Stability of Fatty Acid Composition in Seal Blubber During Long-Term Storage

Marine Ecology - Progress Series
EvolutionEcologySystematicsAquatic ScienceBehavior
2012English

Rational Design of Rabies Vaccine Formulation for Enhanced Stability

Turkish Journal of Medical Sciences
Medicine
2017English

Review of Grippol Family Vaccine Studies and Modern Adjuvant Development

Epidemiology and Vaccinal Prevention
2019English

Fiscal Composition and Long-Term Growth

Applied Economics
EconomicsEconometrics
2013English

Physical Stability and Antioxidant Activity Assay of a Nanoemulsion Gel Formulation Containing Tocotrienol

International Journal of Applied Pharmaceutics
Pharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy